Chief Strategy Officer Mitchell Krassan sold $677K of TherapeuticsMD, Inc.

Sold$676,920

$2.26Price

300,000Shares

−100%Stake

What TXMD did after the filing

Prices for TXMD after this filing aren't in yet.

Traded Mon, Feb 3. Filed Wed, Feb 5, 1:07 PM ET, during the session. Not investment advice.